Is a complete MIRM research report available?

No complete published report is available for Mirum Pharmaceuticals, Inc. (MIRM) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Mirum Pharmaceuticals, Inc. (MIRM)

NASDAQ: MIRM · USD

$108

-4.66 (-4.2%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-30 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first MIRM analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	6.6B
Revenue (ttm)	569.6M
Net income (ttm)	-798.8M
EPS (ttm)	-$15.2
Shares out	61M
Volume	682,485
Beta	0.48
Price target	$147	+36.2%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 569.6M
Net income (ttm): -798.8M
EPS (ttm): -$15.2
Market cap: 6.6B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	38.3B	72.6x	8.9x	78.4%	+49.7%	-11.8%	Strong Buy
ARGX	argenx SE	55.2B	32.2x	10.4x	50.6%	+58.8%	+48.3%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All MIRM indicators

Market & fundamental data

Available fields

214

Groups with data

Currency

USD

Showing 214 of 214 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001759425
Company name	Mirum Pharmaceuticals, Inc.
Country	United States
Country code	US
Cusip	604749101
Employees	418
Employees Change	46%
Employees Change Percent	12.37
Enterprise value	$6.5B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2019-07-18
Isin	US6047491013
Last refreshed	2026-07-30
Market cap	$6.6B
Market cap category	Mid-Cap
Price	$108
Price currency	USD
Rev Per Employee	1,362,700.96x
Sector	Healthcare
Sector PE	45.64
Sector PE Fwd	24.21
Sic	2834
Symbol	MIRM
Website	https://www.mirumpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-12.18%
EV Sales Forward	9.32x
EV/Sales	11.41x
FCF yield	-2.63%
P/B ratio	27.03x
P/S ratio	11.52x
PS Forward	9.41x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-139.82%
EBITDA Margin	-135.42%
Gross margin	81.39%
Gross Profit	$463.6M
Gross Profit Growth	58.53%
Gross Profit Growth Q	48%
Gross Profit Growth3 Y	78.99%
Net Income	$-798.8M
Net Income Growth Years	2%
Pretax Margin	-140%
Profit Margin	-140.24%
Profit Per Employee	$-1.9M
ROA	-5.94
Roa5y	-17.92
ROCE	-128.9
ROE	-335.8
Roe5y	-58.06
ROIC	-8.41

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	109.02%
Cagr3y	60.95%
Cagr5y	50.47%
EPS Growth Years	3
Revenue Growth	50.19x
Revenue Growth Q	43.28x
Revenue Growth Quarters	16x
Revenue Growth Years	4x
Revenue Growth3 Y	81.18x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.72
Assets	$890.9M
Cash	$386.3M
Current Assets	$569.4M
Current Liabilities	$272.8M
Debt	$323.8M
Debt Equity	$1.34
Equity	$242.5M
Interest Coverage	-55.27
Liabilities	$648.4M
Long Term Assets	$321.5M
Long Term Liabilities	$375.6M
Net Cash	$62.5M
Net Cash By Market Cap	$0.95
Net Debt Equity	$-0.26
Tangible Book Value	$-11.7M
Tangible Book Value Per Share	$-0.19
WACC	6.76

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.09
Inventory Turnover	4.42
Net Working Capital	$-87.3M
Quick ratio	1.9
Working Capital	$296.6M
Working Capital Turnover	$1.96

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-9.74%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	108.91%
200-day SMA	92.14
3Y total return	317.1%
50-day SMA	108.8
50-day SMA vs 200-day SMA	50over200
5Y total return	671.11%
All Time High	130
All Time High Change	-17.25%
All Time High Date	2026-07-09
All Time Low	6.51
All Time Low Change	1,551.62%
All Time Low Date	2019-11-20
ATR	5
Beta	0.48
Beta1y	1.07
Beta2y	0.78
Ch YTD	36.18
High	112.4
High52	130
High52 Date	2026-07-09
High52ch	-17.25%
Low	107
Low52	50.25
Low52 Date	2025-08-06
Low52ch	114.07%
Ma50ch	-1.15%
Premarket Change Percent	0.45
Premarket Price	$113
Premarket Volume	573
Price vs 200-day SMA	16.75%
RSI	38.68
RSI Monthly	72.68
RSI Weekly	55.82
Sharpe ratio	1.75x
Sortino ratio	2.82
Total Return	-9.74%
Tr YTD	36.18
Tr1m	-13.09%
Tr1w	-6.04%
Tr3m	14.44%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	13
Analyst Count Top	9
Analyst Price Target Top	$148
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.8
Earnings Revenue Estimate	165,546,928x
Earnings Revenue Estimate Growth	29.55x
Operating Income	$-75.1M
Operating margin	-13.19
Price target	$147
Price Target Change	$36.19
Price Target Change Top	$37.79

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	52,464,162%
Float Percent	86.03%
Shares Insiders	1.37%
Shares Institutions	100.79%
Shares Out	60,981,227
Shares Qo Q	17.24%
Shares Yo Y	9.74%
Short Float	13.86%
Short Ratio	6.69
Short Shares	11.93

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-264.4M
Adjusted OCF	-262,798,000
Average Volume	634,439.2x
Bv Per Share	3.98
CAPEX	$-1.6M
Ch1m	-13.09
Ch1w	-6.04
Ch1y	108.9
Ch3m	14.44
Ch3y	317.1
Ch5y	671.1
Ch6m	6.66
Change	-4.15%
Change From Open	-3.98
Close	112.2
Days Gap	-0.18
Depreciation Amortization	25,066,000
Dollar Volume	73,414,911.4
Earnings Date	2026-08-05
Earnings Time	amc
EBIT	$-796.4M
EBITDA	$-771.4M
EPS	$-15.17
F Score	3
FCF	$-172.6M
FCF EV Yield	-2.66x
FCF Per Share	$-2.83
Financing CF	303,862,000
Fiscal Year End	December
Founded	2,018
Income Tax	$1.4M
Investing CF	-19,389,000
Ipr	617.1
Iprfo	727.5
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-02-25
Ma150	99.36
Ma150ch	8.26%
Ma20	119.1
Ma20ch	-9.66%
Net CF	114,393,000
Next Earnings Date	2026-08-05
Open	112
Optionable	Yes
Position In Range	10.89
Post Close	107.6
Postmarket Change Percent	-2.39
Postmarket Price	$105
Ppne	15,059,000
Pre Close	112.2
Price Date	2026-07-29
Relative Volume	1.08x
Revenue	569,609,000x
SBC By Revenue	16.12x
Share Based Comp	91,823,000
Tax By Revenue	0.24x
Tr6m	6.66%
Us State	California
Volume	682,485
Z Score	1.82

Mirum Pharmaceuticals, Inc. (MIRM)

Coverage state: Market snapshot only — no published research

Generate the first MIRM analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · MIRM

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All MIRM indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on MIRM

Frequently asked questions